Vaxcyte (PCVX) Receivables (2019 - 2025)
Vaxcyte (PCVX) reported Receivables of $21.4 million for Q4 2025, up 3.36% year-over-year from $20.7 million in Q4 2024, and up 5239.0% quarter-over-quarter from $400000.0 in Q3 2025.
Vaxcyte (PCVX) Receivables (2019 - 2025) Analysis & Trends
Vaxcyte (PCVX) has 7 years of Receivables data on file, last reported at $21.4 million in Q4 2025.
- Receivables for Q4 2025 came in at $21.4 million, up 3.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.4 million (up 3.36% YoY), and the FY2025 annual result was $21.4 million, up 3.36% from the prior year.
- Receivables rose to $21.4 million in Q4 2025 per PCVX's latest filing, from $400000.0 in the prior quarter.
- Over five years, Receivables peaked at $21.4 million in Q4 2025 and troughed at $100000.0 in Q1 2022.
- A 5-year average of $5.7 million and a median of $3.0 million in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2023 and 2025: Receivables soared 662.57% in 2023, then tumbled 98.82% in 2025.
- A 5-year view of Receivables shows it stood at $1.2 million in 2021, then jumped by 220.67% to $3.8 million in 2022, then slipped by 6.5% to $3.6 million in 2023, then jumped by 474.26% to $20.7 million in 2024, then climbed by 3.36% to $21.4 million in 2025.
- Business Quant data shows PCVX's Receivables at $21.4 million in Q4 2025, $400000.0 in Q3 2025, and $100000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.36 Mn |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Dec 31, 2024 | 20.66 Mn |
| Sep 30, 2024 | 17.87 Mn |
| Jun 30, 2024 | 8.48 Mn |
| Mar 31, 2024 | 8.12 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Dec 31, 2022 | 3.85 Mn |
| Sep 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 1.10 Mn |
| Mar 31, 2021 | 1.90 Mn |
| Dec 31, 2020 | 1.00 Mn |
| Sep 30, 2020 | 800,000.00 |